Skip to main content

Lipidemia

0
Pipeline Programs
1
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

NewAmsterdam Pharma
NewAmsterdam PharmaNARRDEN, Netherlands
2 programs
obicetrapib 10 mg + ezetimibe 10 mg FDC dailyPHASE_31 trial
obicetrapib 10 mg + ezetimibe 10 mg FDC dailyPHASE_31 trial
Active Trials
NCT07219602Recruiting300Est. Jun 2028
NCT06305559Active Not Recruiting300Est. Feb 2028

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
NewAmsterdam Pharmaobicetrapib 10 mg + ezetimibe 10 mg FDC daily
NewAmsterdam Pharmaobicetrapib 10 mg + ezetimibe 10 mg FDC daily

Clinical Trials (2)

Total enrollment: 600 patients across 2 trials

NCT07219602NewAmsterdam Pharmaobicetrapib 10 mg + ezetimibe 10 mg FDC daily

A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome

Start: Dec 2025Est. completion: Jun 2028300 patients
Phase 3Recruiting
NCT06305559NewAmsterdam Pharmaobicetrapib 10 mg + ezetimibe 10 mg FDC daily

A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque

Start: May 2024Est. completion: Feb 2028300 patients
Phase 3Active Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 600 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.